Search results for "authorisation"

showing 5 items of 5 documents

Family Matters : Abusing Family Refresh Tokens to Gain Unauthorised Access to Microsoft Cloud Services Exploratory Study of Azure Active Directory Fa…

2022

Azure Active Directory (Azure AD) is an identity and access management service used by Microsoft 365 and Azure services and thousands of third-party service providers. Azure AD uses OIDC and OAuth protocols for authentication and authorisation, respectively. OAuth authorisation involves four parties: client, resource owner, resource server, and authorisation server. The resource owner can access the resource server using the specific client after the authorisation server has authorised the access. The authorisation is presented using a cryptographically signed Access Token, which includes the identity of the resource owner, client, and resource. During the authorisation, Azure AD assigns Ac…

Azure Active DirectoryauthorisationpilvipalvelutpääsynvalvontatodentaminenOIDCOAuthauthenticationprivilege escalationsecurityFRTtietoturvaAzure AD
researchProduct

Zasięg korporacyjnego upoważnienia aplikanta do zastępstwa

2023

Upoważnienie aplikanta do zastępstwa funkcjonuje od dawna. Jako że ma charakter tylko albo aż upoważnienia korporacyjnego, stąd też na tym tle jest ono różnie postrzegane. Do tego dochodzą dylematy w zakresie pełnienia przez profesjonalnego pełnomocnika funkcji kuratora, a także kwestia udzielenia upoważnienia do zastępstwa dla aplikanta czy nawet substytucji procesowej dla innego profesjonalnego pełnomocnika w osobie adwokata lub radcy prawnego. Wielość wątków z uwagi na szerokie spektrum aktywności aplikanta, co wiązać należy z odbywaną przez niego aplikacją adwokacką albo radcowską, pociąga za sobą konieczność umiejscowienia go w szeroko rozumianym wymiarze sprawiedliwości jako osoby qua…

authorisation to defendtrainee advocatekorporacje prawniczeprofesjonalny pełnomocnik procesowyurgent legal actionsubstitution power of attorneyprofessional litigation representativekuratorpełnomocnictwo substytucyjnedefence attorneypower of attorney to represent in court proceedingsguardian ad litemupoważnienie do obronynagła czynność procesowatrainee attorneyat lawadvocateattorney-at-lawadwokatpełnomocnictwo procesoweradca prawnydefence secrecytajemnica obrończalaw corporationsobrońcaupoważnienie korporacyjne do zastępstwaaplikant radcowskicorporate mandate for representationaplikant adwokackiPalestra
researchProduct

Decision-cache based XACML authorisation and anonymisation for XML documents

2012

Author's version of an article in the journal: Computer Standards and Interfaces. Also available from the publisher at: http://dx.doi.org/10.1016/j.csi.2011.10.007 This paper describes a decision cache for the eXtensible Access Control Markup Language (XACML) that supports fine-grained authorisation and anonymisation of XML based messages and documents down to XML attribute and element level. The decision cache is implemented as an XACML obligation service, where a specification of the XML elements to be authorised and anonymised is sent to the Policy Enforcement Point (PEP) during initial authorisation. Further authorisation of individual XML elements according to the authorisation specifi…

authorisationSoftware_OPERATINGSYSTEMSMarkup languageComputer sciencecomputer.internet_protocolXACMLAccess controlIntrusion detection systemcomputer.software_genrecachingXACMLcomputer.programming_languageanonymisationVDP::Mathematics and natural science: 400::Information and communication science: 420::Security and vulnerability: 424AuthenticationDatabasebusiness.industryComputingMilieux_MANAGEMENTOFCOMPUTINGANDINFORMATIONSYSTEMSHardware and ArchitectureCacheprivacy policyWeb servicebusinessLawcomputerSoftwareXMLComputer Standards & Interfaces
researchProduct

Cell therapy medicinal product regulatory framework in Europe and its application for MSC-based therapy development

2012

Advanced therapy medicinal products (ATMPs), including cell therapy products, form a new class of medicines in the European Union. Since the ATMPs are at the forefront of scientific innovation in medicine, specific regulatory framework has been developed for these medicines and implemented from 2009. The Committee for Advanced Therapies (CAT) has been established at the European Medicines Agency (EMA) for centralized classification, certification and evaluation procedures, and other ATMP-related tasks. Guidance documents, initiatives, and interaction platforms are available to make the new framework more accessible for small- and medium-sized enterprises, academia, hospitals, and foundation…

lcsh:Immunologic diseases. Allergymesenchymal stem/progenitor cellMesenchymal stem cells (MSC)ImmunologyReview ArticleCertificationBest interestsAgency (sociology)Hospital Exemption authorisationImmunology and AllergyMedicinemedia_common.cataloged_instanceProduct (category theory)European unionHospital Exemptionmedia_commonbusiness.industrynational competent authorityCommittee for Advanced TherapiesCell therapy medicinal product (CTMP)AuthorizationGuidance documentsCommittee for Advanced Therapies (CAT)Engineering managementNew product developmentadvanced therapy medicinal productlcsh:RC581-607businesscell therapy medicinal productAdvanced therapy medicinal product (ATMP)Frontiers in Immunology
researchProduct

Art. 17 Ordinamento penitenziario

2019

The paper analyses the involvement of external community in the re-education of prisoners

prisonerauthorisationsSettore IUS/16 - Diritto Processuale PenaleEducation
researchProduct